Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 11672809 Methods and compositions for reducing parathyroid levels

OverviewStructured DataIssuesContributorsActivity
Is a
Patent
Patent
0
Current Assignee
EirGen Pharma
EirGen Pharma
0
Date Filed
March 29, 2011
0
Date of Patent
June 13, 2023
0
Patent Application Number
13638845
0
Patent Citations
‌
US Patent 7422758 Sustained release vitamin composition
0
‌
US Patent 8992971 Non-animal soft capsule shell composition having improved disintegration and shell hardness
0
‌
US Patent 9017720 Polysaccharide capsules and method of preparation
0
‌
US Patent 9125823 Controlled release pharmaceutical or food formulation and process for its preparation
0
‌
US Patent 9408858 Method for treating secondary hyperparathyroidism in CKD
0
‌
US Patent 9498486 Method for controlled release oral dosage of a vitamin D compound
0
‌
US Patent 9500661 Methods useful for vitamin D deficiency and related disorders
0
‌
US Patent 9913852 Method of treating and preventing secondary hyperparathyroidism
0
‌
US Patent 10220047 Adjunctive therapy with 25-hydroxyvitamin D and articles therefor
0
‌
US Patent 7122530 24-hydroxyvitamin D, analogs and uses thereof
0
•••
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
11672809
0
Patent Primary Examiner
‌
Shengjun Wang
0
CPC Code
‌
A61K 31/593
0
‌
A61P 5/20
0
‌
A61K 2300/00
0
‌
A61K 31/592
0
‌
A61K 9/4858
0

Find more entities like US Patent 11672809 Methods and compositions for reducing parathyroid levels

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo